Anti Cancer Medicines

Approx. Rs 8,000 / BottleGet Latest Price

Additional Information:

Approx. Rs 1,300 / BottleGet Latest Price

Approx. Rs 29,100 / PER VIALGet Latest Price

• Sterile
• For subctaneous Injection
• Must be constituted befor use
• Store Refrigerated 2 to 8 Degree C (36 to 45 Degree F)

Additional Information:

Approx. Rs 12,500 / stripGet Latest Price

• For oral use only

Additional Information:

Approx. Rs 1,200 / MilligramGet Latest Price

• Paclitaxel is given as an injection or infusion into the vein (intravenous, IV).
• Paclitaxel is an irritant. An irritant is a chemical that can cause inflammation of the vein through which it is given. If the medication escapes from the vein it can cause tissue damage. The nurse or doctor who gives Paclitaxel must be carefully trained. If you experience pain or notice redness or swelling at the IV site while you are receiving Paclitaxel, alert your health care professional immediately.
• Because severe allergic reactions have occurred in some people taking Paclitaxel, you will be asked to take medications to help prevent a reaction. Your doctor will prescribe the exact regimen.
• Paclitaxel is given over various amounts of times and in various schedules.
• There is no pill form of Paclitaxel.
• The amount of Paclitaxel and the schedule that it is given will receive depend on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

Important things to remember about the side effects of Paclitaxel include:

• Most people do not experience all of the side effects listed.
• Side effects are often predictable in terms of their onset and duration.
• Side effects are almost always reversible and will go away after treatment is complete.
• There are many options to help minimize or prevent side effects.
• There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
• The side effects of Paclitaxel and their severity vary depending on how much of the drug is given, and/or the schedule in which it is given.

The following side effects are common (occurring in greater than 30%) for patients taking Paclitaxel:

• Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding.
• Hair loss
• Arthralgias and myalgias, pain in the joints and muscles. (see pain) Usually temporary occurring 2 to 3 days after Paclitaxel, and resolve within a few days.
• Peripheral neuropathy (numbness and tingling of the hands and feet)
• Nausea and vomiting (usually mild)
• Diarrhea
• Mouth sores
• Hypersensitivity reaction. Fever, facial flushing, chills, shortness of breath, or hives after Paclitaxel is given (see allergic reaction). The majority of these reactions occur within the first 10 minutes of an infusion. Notify your healthcare provider immediately (premedication regimen has significantly decreased the incidence of this reaction).

The following are less common side effects (occurring in 10-29%) for patients receiving Paclitaxel:

• Swelling of the feet or ankles (edema).
• Increases in blood tests measuring liver function. These return to normal once treatment is discontinued (see liver problems).
• Low blood pressure (occurring during the first 3 hours of infusion).
• Darkening of the skin where previous radiation treatment has been given (radiation recall - see skin reactions).
• Nail changes (discoloration of nail beds - rare) (see skin reactions).

Additional Information:

Approx. Rs 4,088 / PackGet Latest Price

Additional Information:

Approx. Rs 0.5 / UnitGet Latest Price

• Actove omgredoemt Human Albumin (low Salt) 
• Solution for infusion Intravenous use

Additional Information:

Product Price :Get Latest Price

• Nanosomal Docetaxel for Intravenous Infusion use only

Additional Information:

Product Price :Get Latest Price

Pemgem is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. Pemgem is not indicated for patients who have a different type of NSCLC called squamous cell.

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

• Sterile single dose vial

Additional Information:

Product Price :Get Latest Price

• Suspension for intratracheal administration 3 ml (80 mg/ml)
• Suspension for intratracheal administration 1.5 ml (80 mg/ml)

Additional Information:

Product Price :Get Latest Price

Other Details:

• Single Dose Vial
• For IV infusion only

Below are the Competitor brands available with D.Vijay Pharma Pvt. Ltd. Kindly see the table file below.

Additional Information:

Product Price :Get Latest Price

• For intravenous Infusion Combipack
• One Single-use vial
• One diluent vial

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

• Each pack contains
• 1 Vial with 858 mg of Lyophilised powder Containing 440 mg of Trastuzumab
• 1 vial with 20 ml Solvent of bicelits (Trastuzumab 440 mg

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

Additional Information: